Recombinant CEACAM5 (Tusamitamab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA, WB
Hôte: Human, Souris
Chimeric
unconjugated
Recombinant Antibody
-
- Antigène
- CEACAM5 (Tusamitamab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
- Human, Souris
- Expression System
- Mammalian cells
-
Clonalité
- Chimeric
-
Conjugué
- Cet anticorp CEACAM5 (Tusamitamab Biosimilar) est non-conjugé
- Application
- ELISA, Western Blotting (WB)
- Fonction
- Tusamitamab Biosimilar - Anti-CEACAM5 mAb - Research Grade
- Attributs du produit
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Pureté
- > 85%
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
anti-CEACAM5 (Tusamitamab Biosimilar) (Glu239Asp-Mutant), (Met241Leu-Mutant) antibody
Research Grade Reactivité: Humain ELISA, FACS Hôte: Souris Chimeric unconjugated
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS buffer PH7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- CEACAM5 (Tusamitamab Biosimilar)
- Classe de substances
- Biosimilar
- Sujet
- Tusamitamab is an IgG1 monoclonal antibody that targets CEACAM5. Tusamitamab can be used to synthesize Tusamitamab ravtansine, which is a first-in-class humanized antibody-drug conjugate (ADC) that combines Tusamitamab and DM4 (a potent maytansine derivative).
- Numéro CAS
- 2349294-95-5
-
Vous êtes ici:
